Neuroretinal thickness and macular vessel density decline as part of normal aging, mimicking some signs of glaucoma.

Clinical trials continue to be a driving force in ophthalmology, propelling the development of innovative treatments and ...

Ocugen has announced positive preliminary 12-month data from its phase 2 ArMaDa trial evaluating OCU410 (AAV5-RORA) for the ...

Check out our latest jolly merch at For brand partnerships and enquiries please email [email protected] Special thanks ...

Regardless of whether it is a swept-source or spectral-domain platform, OCT angiography is comparably useful for monitoring ...

About 10% of the U.S. population fits into the highest-risk category, with a 20% or higher risk of a cardiac event; 54% are ...

January is Glaucoma Awareness Month, prompting Rutgers Health experts to underscore the importance of early detection and ...

Exposure to blue light doesn't have adverse effects on your eye health. It can, however, disrupt your circadian rhythm. Using blue light filters may help reduce the effects of blue light exposure ...

The hardest part to stomach about “28 Years: The Bone Temple” is its meaninglessness. The second part of a planned trilogy, ...

Hemodialysis significantly alters anterior and posterior eye segments, affecting parameters like anterior chamber depth, lens ...

In October 2001 a Los Angeles County grand jury indicted Saldivar on six counts of murder and one count of attempted murder.

A new study demonstrates the effectiveness of a widely-used eye injection to manage the previously untreatable rare condition ...